Literature DB >> 17101659

Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development.

Peter Mitchell1, Conrad Germain, Pier Luigi Fiori, Wafa Khamri, Graham R Foster, Subrata Ghosh, Robert I Lechler, Kathleen B Bamford, Giovanna Lombardi.   

Abstract

Helicobacter pylori causes chronic gastric infection that affects the majority of the world's population. Despite generating an inflammatory response, the immune system usually fails to clear the infection. Since dendritic cells (DCs) play a pivotal role in shaping the immune response, we investigated the effects of H. pylori on DC function. We have demonstrated that H. pylori increased the expression of activation markers on DCs while upregulating the inhibitory B7 family molecule, PD-L1. Functionally, H. pylori-treated DCs resulted in the production of interleukin-10 (IL-10) and IL-23 but not of alpha interferon (IFN-alpha). While very little or no IL-12 was produced to H. pylori alone, simultaneous ligation of CD40 on DCs induced IL-12 release. We also demonstrated that DCs treated with H. pylori-induced IFN-gamma production by allogeneic naive T cells. However, stimulation of DCs with H. pylori for an extended period of time impaired their ability to produce cytokines after CD40 ligation and limited their ability to promote IFN-gamma release, suggesting that the DCs had become exhausted by the prolonged stimulation. The effect of chronic infection with H. pylori on DC function was further investigated by focusing on DC development. Demonstrating that monocytes differentiated into DCs in the presence of H. pylori exhibited an exhausted phenotype with an impaired ability to produce IL-12 and a downregulation of CD1a. Our results raise the possibility that in chronic H. pylori infection DCs become exhausted after prolonged antigen exposure leading to suboptimal Th1 development. This effect may contribute to persistence of H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101659      PMCID: PMC1828488          DOI: 10.1128/IAI.00228-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa.

Authors:  H A Haeberle; M Kubin; K B Bamford; R Garofalo; D Y Graham; F El-Zaatari; R Karttunen; S E Crowe; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

3.  Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype.

Authors:  K B Bamford; X Fan; S E Crowe; J F Leary; W K Gourley; G K Luthra; E G Brooks; D Y Graham; V E Reyes; P B Ernst
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

4.  Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells.

Authors:  Katharina Kranzer; Liane Söllner; Michael Aigner; Norbert Lehn; Ludwig Deml; Michael Rehli; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Type I interferons inhibit maturation and activation of mouse Langerhans cells.

Authors:  Hideki Fujita; Akihiko Asahina; Yayoi Tada; Hiromi Fujiwara; Kunihiko Tamaki
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

6.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.

Authors:  C L Karp; M Wysocka; X Ma; M Marovich; R E Factor; T Nutman; M Armant; L Wahl; P Cuomo; G Trinchieri
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

7.  Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype.

Authors:  F Sommer; G Faller; P Konturek; T Kirchner; E G Hahn; J Zeus; M Röllinghoff; M Lohoff
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer.

Authors:  Steffen Backert; Tobias Schwarz; Stephan Miehlke; Christian Kirsch; Christian Sommer; Terry Kwok; Markus Gerhard; Ulf B Goebel; Norbert Lehn; Wolfgang Koenig; Thomas F Meyer
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

9.  Molecular analysis of Helicobacter pylori-associated gastric inflammation in naïve versus previously immunized mice.

Authors:  Wibke Rahn; Raymond W Redline; Thomas G Blanchard
Journal:  Vaccine       Date:  2004-12-21       Impact factor: 3.641

Review 10.  Mobilizing dendritic cells for tolerance, priming, and chronic inflammation.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  41 in total

1.  Human primary gastric dendritic cells induce a Th1 response to H. pylori.

Authors:  D Bimczok; R H Clements; K B Waites; L Novak; D E Eckhoff; P J Mannon; P D Smith; L E Smythies
Journal:  Mucosal Immunol       Date:  2010-03-17       Impact factor: 7.313

2.  CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection.

Authors:  Taslima T Lina; Irina V Pinchuk; Jennifer House; Yoshio Yamaoka; David Y Graham; Ellen J Beswick; Victor E Reyes
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

3.  Emerging role of IL-23/IL-17 axis in H pylori-associated pathology.

Authors:  Roberta Caruso; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

4.  Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen.

Authors:  Brodie Miles; Ibrahim Zakhary; Ahmed El-Awady; Elizabeth Scisci; Julio Carrion; John C O'Neill; Aaron Rawlings; J Kobi Stern; Cristiano Susin; Christopher W Cutler
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

Review 5.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

6.  Helicobacter pylori impairs murine dendritic cell responses to infection.

Authors:  Ya-Hui Wang; Jean-Pierre Gorvel; Yen-Ting Chu; Jiunn-Jong Wu; Huan-Yao Lei
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

7.  Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice.

Authors:  Marianne Quiding-Järbrink; Sukanya Raghavan; Malin Sundquist
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

8.  Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice.

Authors:  John Y Kao; Min Zhang; Mark J Miller; Jason C Mills; Baomei Wang; Maochang Liu; Kathyn A Eaton; Weiping Zou; Bradford E Berndt; Tyler S Cole; Tomomi Takeuchi; Stephanie Y Owyang; Jay Luther
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

9.  Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.

Authors:  Trevelyan R Menheniott; Louise O'Connor; Yok Teng Chionh; Jan Däbritz; Michelle Scurr; Benjamin N Rollo; Garrett Z Ng; Shelley Jacobs; Angelique Catubig; Bayzar Kurklu; Stephen Mercer; Toshinari Minamoto; David E Ong; Richard L Ferrero; James G Fox; Timothy C Wang; Philip Sutton; Louise M Judd; Andrew S Giraud
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

10.  DC-LAMP+ dendritic cells are recruited to gastric lymphoid follicles in Helicobacter pylori-infected individuals.

Authors:  Malin Hansson; Malin Sundquist; Susanne Hering; B Samuel Lundin; Michael Hermansson; Marianne Quiding-Järbrink
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.